...
首页> 外文期刊>Majallah-i pizishki-i Urumiyah. >MOLECULAR STUDY OF E148Q MUTATION IN EXON 2 OF MEFV GENE IN PATIENTS WITH PREMATURE CORONARY ARTERY DISEASE
【24h】

MOLECULAR STUDY OF E148Q MUTATION IN EXON 2 OF MEFV GENE IN PATIENTS WITH PREMATURE CORONARY ARTERY DISEASE

机译:早发冠心病患者MEFV基因第2外显子E148Q突变的分子生物学研究

获取原文
           

摘要

Background & Aims : Recent studies have shown that some of the MEFV gene mutations are common in patients with coronary artery disease. The present study was designed to investigate the presence or absence of E148Q mutation in exon 2 of MEFV gene in patients with premature coronary artery disease. Materials & Methods : In this study, 90 patients with coronary artery disease were voluntarily selected for molecular analysis of the E148Q mutation in the exon 2 of the MEFV gene. 2-3 ml of peripheral blood was collected in tubes containing EDTA. Genomic DNA was extracted using " salting out " method. RFLP-PCR was used to determine the E148Q mutation. Results : Of 90 patients studied, 7 (7.8%) patients were heterozygous for the E148Q mutation. In other words, of 180 chromosomes examined, 7 chromosomes (3.9%) had a mutated allele regarding E148Q mutation. In this study, the E148Q mutation was not found to be homozygote in tested samples. Conclusion : It can be concluded that E148Q mutation is not a risk factor for coronary artery disease in the tested group.
机译:背景与目的:最近的研究表明,某些MEFV基因突变在冠心病患者中很常见。本研究旨在调查早发性冠心病患者MEFV基因第2外显子中是否存在E148Q突变。材料与方法:在这项研究中,自愿选择90例冠心病患者进行MEFV基因第2外显子E148Q突变的分子分析。在含有EDTA的试管中收集2-3ml的外周血。使用“盐析”方法提取基因组DNA。 RFLP-PCR用于确定E148Q突变。结果:在研究的90名患者中,有7名(7.8%)患者的E148Q突变是杂合的。换句话说,在检查的180条染色体中,有7条染色体(3.9%)具有与E148Q突变有关的突变等位基因。在这项研究中,在测试样品中未发现E148Q突变是纯合子。结论:可以得出结论,E148Q突变不是受测人群冠心病的危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号